RAFARM
We evolve beyond the obvious; we make a positive impact on people’s lives and ensure a healthier future.
How far can we get?
Well, we take a step forward, daily.
Every day we discover new paths
Every day we go beyond the obvious, we march ahead towards a healthier future.
We are RAFARM, innovation-driven, dynamically growing, and one of the largest Greek pharmaceutical companies with an outward-looking orientation.
We invest 10% of net turnover in Research and Development
>100 RAFARM development products
10 new products are being developed
every year by the R&D department
40 active pharmaceutical technology projects every year
1,100 active pharmaceutical licenses formulations
We create new employment opportunities of high expertise
We expand our exports worldwide (>60 countries)
We have three state-of-the-art production units, new independent
Research Center and storage space, with a total area of 16,000 sq.m.
We are implementing one of the largest investment programs for years
2021-2025 in Greece, amounting to €65 million
We rapidly grow our commercial activity in the domestic market and we are expanding our product portfolio.
At RAFARM, we are driven by knowledge; that’s why we are constantly developing thus enhancing our expertise in the development and production of ophthalmic and injectable pharmaceutical products.
We achieve results that are beyond the obvious due to our team of highly knowledgeable R&D scientists, the cutting-edge technology we apply in production and our holistic approach to regulatory affairs.
We act with promptness and agility. We adapt to the needs of the constantly developing pharmaceutical field making use of technology, our customer-oriented approach and primary focus on the individual.
Why to partner with us?
o Enriched options of complex pharmaceutical products
o Flexible business partnerships worldwide
o R&D extensive expertise on sterile forms
o Focus on time to market
o Supplier reliability
Company Details
- Employees
- 437
- Founded
- -
- Address
- Agiou Louka, Athens,peania 10000,greece
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- rafarm.gr
- Keywords
- Contract Manufacturing, Development and contract manufacturing Opthalmics, Development injectables, Marketing pharmaceutical products, Adaptive end-to-end CDMO Solutions, Licensing and Supply, Co-development, Distribution, Marketing and promotion in local markets (Greece and Cyprus), Flexible business partnerships, Enriched options of complex pharmaceutical products.
- HQ
- Athens , Peania
Rafarm S.a. Questions
Rafarm S.A.'s website is rafarm.gr
Rafarm S.A.'s LinkedIn profile is https://gr.linkedin.com/company/rafarm-s.a
Rafarm S.A. has
437 employees.
View email and phone details for 437
employees at Rafarm S.A..
Rafarm S.A.'s industry is
Pharmaceutical Manufacturing
Rafarm S.A.'s top competitors are
Famar,
Genepharm Sa,
Apivita Sa,
Elpen Pharmaceutical Co. Inc.,
Demo Pharmaceuticals S.a.,
Uni-Pharma Pharmaceutical Laboratories S.a.,
Pharmathen,
Vianex Sa,
Lavipharm,
Bennett Pharmaceutical Industry.
Rafarm S.A.'s categories are Pharmaceutical Manufacturing
Rafarm S.A.'s founding year is 1974
